| |
| Device | TREO® Abdominal Stent-Graft System |
| Generic Name | SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT |
| Applicant | Bolton Medical, Inc. 799 International Pkwy. Sunrise, FL 33325 |
| PMA Number | P190015 |
| Date Received | 06/03/2019 |
| Decision Date | 05/04/2020 |
| Product Code |
MIH |
| Docket Number | 20M-1311 |
| Notice Date | 05/07/2020 |
| Advisory Committee |
Cardiovascular |
| Clinical Trials | NCT01328197
|
| Expedited Review Granted? | No |
| Combination Product | No |
| Predetermined Change Control Plan Authorized | No |
| Recalls | CDRH Recalls |
Approval Order Statement Approval for TREO® Abdominal Stent-Graft System. This device is indicated for use in the endovascular treatment of patients with infrarenal abdominal aortic and aorto-iliac aneurysms with the following characteristics:1. Adequate iliac or femoral access compatible with the required delivery systems and accessories;2. Proximal aortic landing zone with: 2a. Infrarenal landing neck length of >= 15mm; 2b. Aortic neck diameters >= 17 mm and <= 32 mm; 2c. Suprarenal neck angle of <= 45 degrees; 2d. Infrarenal neck angle of <= 60 degrees. 3. Distal iliac landing zone with: 3a. an inside diameter of 8 mm – 13 mm and a length of >= 10 mm; or 3b. an inside diameter of > 13 mm – 20 mm and a length of >= 15 mm.4. Minimum overall AAA treatment length (proximal landing location to distal landing location) of 13 cm; and5. Minimum overall length from the lowest renal artery to the aortic bifurcation of 9 cm. |
| Approval Order | Approval Order |
| Summary | Summary of Safety and Effectiveness |
| Labeling | Labeling Labeling Part 2 |
| Post-Approval Study | Show Report Schedule and Study Progress |
| Supplements: |
S001 S002 S003 S004 S005 S006 S007 S008 S009 S010 S012 S013 S014 S016 S017 S018 S019 S020 S021 S022 S023 S024 S025 S026 S027 S029 |